Tachyphylaxis to PACAP-27 after inhibition of NO synthesis: A loss of adenylate cyclase activation

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 5 46-5, 1999, Pages

  Whalen, Erin J ^a   Johnson, Alan Kim ^a,b   Lewis, Stephen J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b E11 SSH   (United States)

Author keywords

Adenosine 3',5' cyclic monophosphate; G(s) protein coupled receptors; Nitric oxide; Nitrosyl factors; Vasodilation

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVATION; HEMODYNAMIC PARAMETERS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SYNTHESIS; TACHYPHYLAXIS; VASODILATATION;

EID: 0032805733     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.5.r1453     Document Type: Article

References (32)

1. Arimura, A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul. Pept. 37: 287-303, 1992.
2. Christopher, J. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim. Biophys. Acta 1154: 183-199, 1993.
3. Davisson, R. L., J. N. Bates, A. K. Johnson, and S. J. Lewis. Use-dependent loss of acetylcholine- and bradykinin-mediated vasodilation after nitric oxide synthase inhibition - evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 28: 354-360, 1996.
4. Davisson, R. L., O. S. Possas, S. P. Murphy, and S. J. Lewis. Neurogenically derived nitrosyl factors mediate sympathetic vasodilation in the hindlimb of the rat. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H2369-H2376, 1997.
5. Davisson, R. L., R. A. Shaffer, A. K. Johnson, and S. J. Lewis. Stimulation of lumbar sympathetic nerves may produce hindlimb vasodilation via the release of pre-formed stores of nitrosyl factors. Neuroscience 72: 881-887, 1996.
6. Davission, R. L., R. A. Shaffer, A. K. Johnson, and S. J. Lewis. Use-dependent loss of active sympathetic neurogenic vasodilation following nitric oxide synthase inhibition in conscious rats - evidence for the presence of preformed stores of nitric oxide-containing factors. Hypertension 28: 347-353, 1996.
7. Davisson, R. L., M. D. Travis, J. N. Bates, and S. J. Lewis. Hemodynamic effects of L- and D-S-nitrosocysteine in the rat: stereoselective S-nitrosothiol recognition sites. Circ. Res. 79: 256-262, 1996.
8. Haywood, J. R., R. A. Shaffer, C. Fastenow, G. D. Fink, and M. J. Brody. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am. J. Physiol. 241 (Heart Circ. Physiol. 10): H273-H278, 1981.
9. Hausdorff, W. P., M. G. Caron, and R. J. Lefkowitz. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4: 2881-2889, 1990.
10. Ignarro, L. J. Nitric oxide: a novel signal transduction mechanism for transcellular communication. Hypertension 16: 477-483, 1990.
11. Lander, H. M., P. K. Sehajpal, and A. Novogrodsky. Nitric oxide signaling: a possible role for G-proteins. J. Immunol. 151: 7182-7187, 1993.
12. Minkes, R. K., T. J. McMahon, T. R. Higuera, W. A. Murphy, D. H. Coy, and P. J. Kadowitz. Analysis of systemic and pulmonary vascular responses to PACAP and VIP: role of adrenal catecholarnines. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1659-H1669, 1992.
13. Minkes, R. K., T. J. McMahon, J. S. Hood, W. A. Murphy, D. H. Coy, D. B. McNamara, and P. J. Kadowitz. Differential effects of PACAP and VIP on the pulmonary and hindquarters vascular beds of the cat. J. Appl. Physiol. 72: 1212-1217, 1992.
14. Miyamoto, A., U. Laufs, C. Pardo, and J. K. Liao. Modulation of bradykinin receptor ligand binding affinity and its coupled G-proteins by nitric oxide. J. Biol. Chem. 272: 19601-19608, 1997.
15. Miyata, A., A. Arimura, R. R. Dahl, N. Minamino, A. Uehara, L. Jiang, M. D. Culler, and D. H. Coy. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164: 567-574, 1939.
16. Miyata, A., L. Jiang, R. D. Dahl, C. Kitada, K. Kubo, M. Fujino, N. Minamino, and A. Arimura. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP 38). Biochem. Biophys. Res. Commun. 170: 643-648, 1990.
17. Myers, P. R., R. L. Minor, Jr., R. Guerra, Jr., J. N. Bates, and D. G. Harrison. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163, 1990.
18. Nandha, K. A., M. A. Benito-Orfila, D. M. Smith, M. A. Ghatei, and S. R. Bloom. Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding. J. Endocrinol. 129: 69-73, 1991.
19. Palczewski, K., and J. L. Benovic. G-protein-coupled receptor kinases. Trends Biochem. Sci. 16: 387-391, 1991.
20. Possas, O. S., and S. J. Lewis. NO-containing factors mediate hindlimb vasodilation produced by superior laryngeal nerve stimulation. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H234-H243, 1997.
21. Poston, L., and P. D. Taylor. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sci. (Colch.) 88: 245-255, 1995.
22. Premont, R. T., J. Inglese, and R. J. Lefkowitz. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9: 175-182, 1995.
23. Shivers, B. D., T. J. Gores, P. E. Gottschall, and A. Ariumura. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 128: 3055-3065, 1991.
24. Spengler, D., C. Waeber, C. Pantaloni, F. Holsboer, J. Bockaert, P. H. Seeburg, and L. Journot. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365: 170-175, 1993.
25. Stamler, J. S., D. J. Singel, and J. Loscalzo. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992.
26. Travis, M. D., L. L. Stoll, J. N. Bates, and S. J. Lewis. L-and D-S-nitroso-β,β-dimethylcysteine differentially increase cGMP in cultured vascular smooth muscle. Eur. J. Pharmacol. 318: 47-53, 1996.
27. Travis, M. D., R. L. Davisson, J. N. Bates, and S. J. Lewis. Hemodynamic effects of L- and D-S-nitroso-β,β-dimethylcysteine in the rat. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H1493-H1501, 1997.
28. Travis, M. D., E. J. Whalen, and S. J. Lewis. Heterologous desensitization of β-adrenoceptor signal transduction in vivo. Eur. J. Pharmacol. 328: R1-R3, 1997.
29. Wallenstein, S., C. L. Zucker, and J. C. Fleiss. Some statistical methods useful in circulation research. Circ. Res. 47: 1-9, 1980.
30. Warren, J. B., L. E. Donnelly, S. Cullen, B. E. Robertson, M. A. Ghatei, S. R. Bloom, and J. MacDermot. Pituitary adenylate cyclase-activating polypeptide: a novel, long-lasting endothelium-independent vasorelaxant. Eur. J. Pharmacol. 197: 131-134, 1991.
31. Whalen, E. J., M. D. Travis, A. K. Johnson, and S. J. Lewis. Rapid tachyphylaxis to the hemodynamic effects of PACAP-27 after inhibition of nitric oxide synthesis. Am. J. Physiol. 276 (Heart Circ. Physiol. 45): H2117-H2126, 1999.
32. Winer, B. J. Statistical Principles of Experimental Design. New York: McGraw-Hill, 1971, pp. 752-809.